ENTITY
Rasonque
Rasonque
PulseAugur coverage of Rasonque — every cluster mentioning Rasonque across labs, papers, and developer communities, ranked by signal.
Total · 30d
2
2 over 90d
Releases · 30d
0
0 over 90d
Papers · 30d
0
0 over 90d
TIER MIX · 90D
TOPICS
TIMELINE
- 2026-08-26 product_launch The FDA approved Rasonque, a new pancreatic cancer drug developed by Revolution Medicines. source
SENTIMENT · 30D
1 day(s) with sentiment data
RECENT · PAGE 1/1 · 2 TOTAL
-
FDA approves Revolution Medicines' pancreatic cancer pill Rasonque
The FDA has approved Rasonque, a new daily pill from Revolution Medicines, designed to target RAS protein mutations that drive tumor growth in pancreatic cancer. This approval marks a significant breakthrough, as it val…
-
FDA approves new pancreatic cancer drug daraxonrasib after trial success
The U.S. FDA has approved daraxonrasib (Rasonque), a new targeted therapy for pancreatic ductal adenocarcinoma (PDAC) in adults whose disease has spread and failed other treatments. This marks a significant advancement …